Quick Takeaways
- MPM BioImpact LLC filed SCHEDULE 13G for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX).
- Disclosed ownership: 7.2%.
- Date of event: 31 Mar 2026.
MPM BioImpact LLC - 31 Mar 2026 SCHEDULE 13G Report for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX)
- Filing Manager
- MPM BioImpact LLC
- Reporting Manager
- MPM BioImpact LLC
- Symbol
- FBRX
- Shares outstanding
- 13,898,361 shares
- Disclosed Ownership
- 1,000,682 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2026, 16:09:03 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MPM BioImpact LLC disclosed 7.2% ownership in Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX) on 31 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2026, 16:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC | 7.2% | 1,000,682 | 1,000,682 | 0 | Christopher Wolf | Chief Financial Officer |